Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2019 2020 2021 2022 2023 2024 2025
Months
January February March April July May June August September October November December
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

DiMTEC hosts second conference on disaster risk reduction
2009-06-02

 
Dr Anthony Turton, the Director: TouchStone Resources (Pty) Ltd. delivered the opening address at this year’s two-day annual international conference on disaster risk reduction that was presented by the Disaster Management Training and Education Centre for Africa (DiMTEC) at the University of the Free State (UFS).

In his presentation: Sitting on the horns of a dilemma: South Africa and its strategic water supply, he said: “We have simply reached the limit of the water resources in South Africa. On the one hand, we deal with the quantity dilemma in terms of strategic water storage. South Africa and Zimbabwe counts under the top 20 countries in the world in terms of dams built. We can only build about ten more dams.”

“On the other hand, we must deal with quantity. Previous solutions are not future solutions. When water is recycled, hormones such as oestrogen do not disappear. We must become creative and do something else,” he said.

“Science can make a difference. The UFS is well placed in terms of its groundwater research. Universities must invest in the necessary technology because the testing of toxins is essential. We must work in ways to prevent toxins from re-entering the water cycle,” he said.

A number of international speakers such as Dr Fabrice Renaud, Associate Director at the United Nations University’s Institute for Environment and Human Security (UNU-EHS) in Bonn, Germany, Dr Eugene Poolman, Chief Forecaster: Disaster Risk Reduction, South African Weather Service, and Prof. Rob Bragg from the Department of Microbial, Biochemical and Food Biotechnology at the UFS, attended the conference, as well as attendees from 11 different countries.

At the conference were, from the left: Mr Andries Jordaan, Director: DiMTEC at the UFS; Dr Ing Jörn Birkmann, Head of Section: Vulnerability Assessment at the United Nations University’s Institute for Environment and Human Security (UNU-EHS); Dr Anthony Turton, Director: TouchStone Resources (Pty) Ltd.; and Dr Fabrice Renaud, Associate Director: UNU-EHS.
Photo: Supplied

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept